Analysis of Chemopredictive Assay for Targeting Cancer Stem Cells in Glioblastoma Patients

Analysis of Chemopredictive Assay for Targeting Cancer Stem Cells in Glioblastoma Patients

Introduction: The prognosis of glioblastoma (GBM) treated with standard-of-care maximal surgical resection and concurrent adjuvant temozolomide (TMZ)/radiotherapy remains very poor (less than 15 months). GBMs have been found to contain a small population of cancer stem cells (CSCs) that contribute t...

Full description

Bibliographic Details
Main Authors: Candace M. Howard, Jagan Valluri, Anthony Alberico, Terrence Julien, Rida Mazagri, Robert Marsh, Hoyt Alastair, Antonio Cortese, Michael Griswold, Wanmei Wang, Krista Denning, Linda Brown, Pier Paolo Claudio
Format: Article
Language:English
Published: Elsevier 2017-04-01
Series:Translational Oncology
Online Access:http://www.sciencedirect.com/science/article/pii/S193652331730013X

Internet

http://www.sciencedirect.com/science/article/pii/S193652331730013X

Similar Items